Retrospective cohort study examines hematologic inflammatory markers' impact on survival in nasopharyngeal carcinoma, suggesting further exploration.
Objective.: To examine the longitudinal trajectories of hematologic inflammatory markers and their prognostic and mediating roles in nasopharyngeal carcinoma (NPC). Methods.: This retrospective cohort study used group-based trajectory modeling (GBTM) on 1,867 NPC patients in Taiwan across three time points during radiotherapy. Results.: A high-inflammation systemic immune-inflammation index (SII), calculated from platelet, neutrophil, and lymphocyte counts on routine blood tests (platelet × neutrophil / lymphocyte), trajectory (3.4% of patients) independently predicted poorer overall survival (adjusted HR, 1.89) and greater odds of disease persistence (adjusted OR, 2.09). Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) trajectories were not significantly associated with outcomes. Disease persistence mediated 14.7% of the total survival effect of SII. Conclusion.: In this exploratory analysis, high-inflammation SII trajectories were associated with inferior survival and increased residual disease risk in NPC. However, as SII was not associated with recurrence and disease persistence explained only a small proportion of the survival association, the pathway linking SII to survival remains unclear and warrants prospective investigation.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: